Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Colorectal Neoplasms 3 Small Cell Lung Carcinoma 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Spinocerebellar Degenerations 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Pancreatic Adenocarcinoma 1 PD-L1-selected Solid Tumors 1 Melanoma 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Chordoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Advanced Solid Malignancies 1 Advanced Rare Malignant Solid Neoplasm 1 Advanced Liver Cancers 1

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Liver Cancers × Tiragolumab × 1 year × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡